Frontiers in Neuroscience,
Год журнала:
2023,
Номер
17
Опубликована: Апрель 3, 2023
Repetitive
physical
insults
to
the
head,
including
those
that
elicit
mild
traumatic
brain
injury
(mTBI),
are
a
known
risk
factor
for
variety
of
neurodegenerative
conditions
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
and
chronic
encephalopathy
(CTE).
Although
most
individuals
who
sustain
mTBI
typically
achieve
seemingly
full
recovery
within
few
weeks,
subset
experience
delayed-onset
symptoms
later
in
life.
As
research
has
focused
on
acute
phase
injury,
there
is
an
incomplete
understanding
mechanisms
related
late-life
emergence
neurodegeneration
after
early
exposure
head
trauma.
The
recent
adoption
Drosophila
-based
models
provides
several
unique
advantages
over
existing
preclinical
animal
models,
tractable
framework
amenable
high-throughput
assays
short
relative
lifespan
conducive
lifelong
mechanistic
investigation.
use
flies
also
opportunity
investigate
important
factors
associated
with
conditions,
specifically
age
sex.
In
this
review,
we
survey
current
literature
examines
sex
as
contributing
trauma-mediated
humans
mammalian
models.
We
discuss
similarities
disparities
between
human
fly
aging,
differences,
pathophysiology.
Finally,
highlight
effective
tool
investigating
underlying
trauma-induced
identifying
therapeutic
targets
treatment
recovery.
ACS Omega,
Год журнала:
2025,
Номер
10(2), С. 1864 - 1892
Опубликована: Янв. 8, 2025
Parkinson's
disease
(PD)
is
a
progressive
neurodegenerative
disorder
that
primarily
affects
movement.
It
occurs
due
to
gradual
deficit
of
dopamine-producing
brain
cells,
particularly
in
the
substantia
nigra.
The
precise
etiology
PD
not
fully
understood,
but
it
likely
involves
combination
genetic
and
environmental
factors.
therapies
available
at
present
alleviate
symptoms
do
stop
disease's
advancement.
Research
endeavors
are
currently
directed
inventing
disease-controlling
aim
inherent
mechanisms
PD.
biomarker
breakthroughs
hold
enormous
potential:
earlier
diagnosis,
better
monitoring,
targeted
treatment
based
on
individual
response
could
significantly
improve
patient
outcomes
ease
burden
this
disease.
research
an
active
evolving
field,
focusing
understanding
mechanisms,
identifying
biomarkers,
developing
new
treatments,
improving
care.
In
report,
we
explore
data
from
CAS
Content
Collection
outline
progress
We
analyze
publication
landscape
offer
perspective
into
latest
expertise
advancements.
Key
emerging
concepts
reviewed
strategies
fight
evaluated.
Pharmacological
targets,
risk
factors,
as
well
comorbid
diseases
explored,
clinical
usage
products
against
with
their
production
pipelines
trials
for
drug
repurposing
examined.
This
review
aims
comprehensive
overview
advancing
current
about
PD,
define
challenges,
assess
growth
prospects
stimulate
efforts
battling
Molecular Psychiatry,
Год журнала:
2024,
Номер
29(2), С. 505 - 517
Опубликована: Янв. 3, 2024
Mitochondrial
DNA
single
nucleotide
polymorphisms
(mtSNPs)
have
been
associated
with
a
reduced
risk
of
developing
Parkinson's
disease
(PD),
yet
the
underlying
mechanisms
remain
elusive.
In
this
study,
we
investigate
functional
role
PD-associated
mtSNP
that
impacts
mitochondrial-derived
peptide
(MDP)
Small
Humanin-like
Peptide
2
(SHLP2).
We
identify
m.2158
T
>
C,
PD
risk,
within
small
open
reading
frame
encoding
SHLP2.
This
results
in
an
alternative
form
SHLP2
(lysine
4
replaced
arginine;
K4R).
Using
targeted
mass
spectrometry,
detect
specific
tryptic
fragments
neuronal
cells
and
demonstrate
its
binding
to
mitochondrial
complex
1.
Notably,
observe
K4R
variant,
exhibits
increased
stability
compared
WT
Additionally,
both
show
enhanced
protection
against
dysfunction
vitro
experiments
confer
PD-inducing
toxin,
1
inhibitor,
mouse
model.
study
sheds
light
on
consequences
C
provides
insights
into
potential
by
which
may
reduce
PD.
Biomolecules,
Год журнала:
2024,
Номер
14(1), С. 73 - 73
Опубликована: Янв. 5, 2024
Parkinson’s
disease
(PD)
is
the
second
most
prevalent
neurodegenerative
movement
disorder
worldwide,
which
primarily
characterized
by
motor
impairments.
Even
though
multiple
hypotheses
have
been
proposed
over
decades
that
explain
pathogenesis
of
PD,
presently,
there
are
no
cures
or
promising
preventive
therapies
for
PD.
This
could
be
attributed
to
intricate
pathophysiology
PD
and
poorly
understood
molecular
mechanism.
To
address
these
challenges
comprehensively,
a
thorough
model
imperative
nuanced
understanding
PD’s
underlying
pathogenic
mechanisms.
review
offers
detailed
analysis
current
state
knowledge
regarding
mechanisms
with
particular
emphasis
on
roles
played
gene-based
factors
in
disease’s
development
progression.
study
includes
an
extensive
discussion
proteins
mutations
primary
genes
linked
including
α-synuclein,
GBA1,
LRRK2,
VPS35,
PINK1,
DJ-1,
Parkin.
Further,
this
explores
plausible
DAergic
neural
loss,
non-motor
non-dopaminergic
pathologies,
risk
associated
The
present
will
encourage
related
research
fields
understand
better
analyze
status
biochemical
might
contribute
design
efficacious
safe
treatment
strategies
future
endeavors.
CNS Neuroscience & Therapeutics,
Год журнала:
2024,
Номер
30(10)
Опубликована: Окт. 1, 2024
Huntington's
disease
(HD)
is
a
devastating
neurodegenerative
that
manifested
by
gradual
loss
of
physical,
cognitive,
and
mental
abilities.
As
the
advances,
age
has
major
impact
on
pathogenic
signature
mutant
huntingtin
(mHTT)
protein
aggregation.
This
review
aims
to
explore
intricate
relationship
between
aging,
mHTT
toxicity,
cellular
senescence
in
HD.
Scientific
data
interplay
mHTT,
HD
were
collected
from
several
academic
databases,
including
PubMed,
Google
Scholar,
Google,
ScienceDirect.
The
search
terms
employed
"AGING,"
"HUNTINGTON'S
DISEASE,"
"MUTANT
HUNTINGTIN,"
"CELLULAR
SENESCENCE."
Additionally,
gather
information
molecular
mechanisms
potential
therapeutic
targets,
was
extended
include
relevant
such
as
"DNA
DAMAGE,"
"OXIDATIVE
STRESS,"
"AUTOPHAGY."
According
research,
aging
leads
worsening
pathophysiology
through
some
processes.
result
accumulation,
promoted,
which
causes
DNA
damage,
oxidative
stress,
decreased
autophagy,
increased
inflammatory
responses.
Pro-inflammatory
cytokines
other
substances
are
released
senescent
cells,
may
worsen
neuronal
damage
course
disease.
It
been
shown
treatments
directed
at
these
pathways
reduce
symptoms
enhance
longevity
experimental
animals,
pointing
new
possibility
treating
condition.
Through
their
amplification
harmful
effects
play
crucial
roles
development
Comprehending
interplays
creates
novel
opportunities
for
measures
targeted
alleviating
enhancing
patients'
quality
life.
Frontiers in Pharmacology,
Год журнала:
2023,
Номер
14
Опубликована: Май 10, 2023
Parkinson’s
disease
(PD),
the
second
most
common
neurodegenerative
worldwide,
often
occurs
in
middle-aged
and
elderly
individuals.
The
pathogenesis
of
PD
is
complex
includes
mitochondrial
dysfunction,
oxidative
stress.
Recently,
natural
products
with
multiple
structures
their
bioactive
components
have
become
one
important
resources
for
small
molecule
drug
research
targeting
dysfunction.
Multiple
lines
studies
proven
that
display
ameliorative
benefits
treatment
by
regulating
Therefore,
a
comprehensive
search
recent
published
articles
between
2012
2022
PubMed,
Web
Science,
Elesvier,
Wliey
Springer
was
carried
out,
focusing
on
original
publications
related
to
against
restoring
This
paper
presented
mechanisms
various
kinds
PD-related
dysfunction
regulation
provided
evidence
are
promising
be
developed
as
drugs
therapeutics.
Journal of Proteome Research,
Год журнала:
2024,
Номер
23(8), С. 3025 - 3040
Опубликована: Апрель 3, 2024
Despite
the
recent
and
increasing
knowledge
surrounding
COVID-19
infection,
underlying
mechanisms
of
persistence
symptoms
for
a
long
time
after
acute
infection
are
still
not
completely
understood.
Here,
multiplatform
mass
spectrometry-based
approach
was
used
metabolomic
lipidomic
profiling
human
plasma
samples
from
Long
COVID
patients
(n
=
40)
to
reveal
mitochondrial
dysfunction
when
compared
with
individuals
fully
recovered
mild
40).
Untargeted
analysis
using
CE-ESI(+/−)-TOF-MS
GC-Q-MS
performed.
Additionally,
LC-ESI(+/−)-QTOF-MS
based
on
an
in-house
library
revealed
447
lipid
species
identified
high
confidence
annotation
level.
The
integration
complementary
analytical
platforms
has
allowed
comprehensive
metabolic
characterization
alterations
in
disease
that
found
46
relevant
metabolites
which
discriminate
between
patients.
We
report
specific
altered
COVID,
mainly
related
decrease
amino
acid
metabolism
ceramide
levels
increase
tricarboxylic
(TCA)
cycle,
reinforcing
evidence
impaired
function.
most
shown
this
study
will
help
better
understand
insights
syndrome
by
providing
deeper
basis
pathology.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Июнь 11, 2024
Abstract
Impairment
of
the
central
nervous
system
(CNS)
poses
a
significant
health
risk
for
astronauts
during
long-duration
space
missions.
In
this
study,
we
employed
an
innovative
approach
by
integrating
single-cell
multiomics
(transcriptomics
and
chromatin
accessibility)
with
spatial
transcriptomics
to
elucidate
impact
spaceflight
on
mouse
brain
in
female
mice.
Our
comparative
analysis
between
ground
control
spaceflight-exposed
animals
revealed
alterations
essential
processes
including
neurogenesis,
synaptogenesis
synaptic
transmission,
particularly
affecting
cortex,
hippocampus,
striatum
neuroendocrine
structures.
Additionally,
observed
astrocyte
activation
signs
immune
dysfunction.
At
pathway
level,
some
spaceflight-induced
changes
exhibit
similarities
neurodegenerative
disorders,
marked
oxidative
stress
protein
misfolding.
integrated
serves
as
stepping
stone
towards
understanding
CNS
impairments
at
level
individual
regions
cell
types,
provides
basis
comparison
future
studies.
For
broader
scientific
impact,
all
datasets
from
study
are
available
through
interactive
data
portal,
well
National
Aeronautics
Space
Administration
(NASA)
Open
Science
Data
Repository
(OSDR).